282 related articles for article (PubMed ID: 11160339)
1. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease.
McCartney-Francis NL; Song X; Mizel DE; Wahl SM
J Immunol; 2001 Feb; 166(4):2734-40. PubMed ID: 11160339
[TBL] [Abstract][Full Text] [Related]
2. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats.
Fletcher DS; Widmer WR; Luell S; Christen A; Orevillo C; Shah S; Visco D
J Pharmacol Exp Ther; 1998 Feb; 284(2):714-21. PubMed ID: 9454819
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide in experimental joint inflammation. Benefit or detriment?
Wahl SM; McCartney-Francis N; Chan J; Dionne R; Ta L; Orenstein JM
Cells Tissues Organs; 2003; 174(1-2):26-33. PubMed ID: 12784039
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
Hallinan EA; Tsymbalov S; Dorn CR; Pitzele BS; Hansen DW; Moore WM; Jerome GM; Connor JR; Branson LF; Widomski DL; Zhang Y; Currie MG; Manning PT
J Med Chem; 2002 Apr; 45(8):1686-9. PubMed ID: 11931623
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
8. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
Vankelecom H; Matthys P; Denef C
Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
[TBL] [Abstract][Full Text] [Related]
10. Differential function of nitric oxide in murine antigen-induced arthritis.
Veihelmann A; Hofbauer A; Krombach F; Dorger M; Maier M; Refior HJ; Messmer K
Rheumatology (Oxford); 2002 May; 41(5):509-17. PubMed ID: 12011373
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats.
Schwartz D; Mendonca M; Schwartz I; Xia Y; Satriano J; Wilson CB; Blantz RC
J Clin Invest; 1997 Jul; 100(2):439-48. PubMed ID: 9218522
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism.
Nédélec E; Abid A; Cipolletta C; Presle N; Terlain B; Netter P; Jouzeau J
Biochem Pharmacol; 2001 Apr; 61(8):965-78. PubMed ID: 11286988
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
[TBL] [Abstract][Full Text] [Related]
14. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion.
Binion DG; Fu S; Ramanujam KS; Chai YC; Dweik RA; Drazba JA; Wade JG; Ziats NP; Erzurum SC; Wilson KT
Am J Physiol; 1998 Sep; 275(3):G592-603. PubMed ID: 9724273
[TBL] [Abstract][Full Text] [Related]
15. Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation.
Day SM; Lockhart JC; Ferrell WR; McLean JS
Ann Rheum Dis; 2004 Dec; 63(12):1564-70. PubMed ID: 15547079
[TBL] [Abstract][Full Text] [Related]
16. Effects of NO synthase inhibitors on the synovial microcirculation in the mouse knee joint.
Veihelmann A; Krombach F; Refior HJ; Messmer K
J Vasc Res; 1999; 36(5):379-84. PubMed ID: 10559678
[TBL] [Abstract][Full Text] [Related]
17. Genetic Models in Applied Physiology. Differential role of nitric oxide synthase isoforms in fever of different etiologies: studies using Nos gene-deficient mice.
Kozak W; Kozak A
J Appl Physiol (1985); 2003 Jun; 94(6):2534-44. PubMed ID: 12562678
[TBL] [Abstract][Full Text] [Related]
18. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms.
Wang R; Ghahary A; Shen YJ; Scott PG; Tredget EE
J Invest Dermatol; 1996 Mar; 106(3):419-27. PubMed ID: 8648170
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
